PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: NatWest posts interim growth; IAG swings to profit

Fri, 28th Jul 2023 07:54

(Alliance News) - Stocks in London are called slightly lower on Friday, with investors having plenty to consider amid the week's swathe of corporate earnings and central bank decisions.

The yen strengthened as the Bank of Japan said it will allow "greater flexibility" in controlling bond yields, as it raised its full-year inflation forecast to 2.5% from its previous estimate of 1.8%.

It said it would continue to allow 10-year JGB yields to "fluctuate in the range of around plus and minus 0.5 percentage points from the target level, while it will conduct yield curve control with greater flexibility regarding the upper and lower bounds of the range as references, not as rigid limits," the central bank said in a statement. The bank also kept its short-term interest rate target unchanged at -0.1%.

Reports of a potential upcoming tweak by the BoJ had come on Thursday ahead of the meeting, pushing the Japanese yen higher against the dollar, and pushing US 10-year yields back above 4%, CMC Markets' Michael Hewson noted. This sent stocks in New York lower, after a mostly positive start, having been boosted by a strong economic growth print for the US.

"The late decline in the US looks set to translate into a weaker European open, even though confidence is growing that the Fed is more or less done when it comes to its rate hiking cycle. Nonetheless, investors will be looking for further evidence of this with the latest core [personal consumption expenditures] deflator, as well as personal spending and income data for June, later this afternoon to support the idea of weaker inflation," said CMC Markets' Michael Hewson.

In early UK company news, Natwest reported a strong first half, with customer deposits stabilising in the second quarter after outflows in the first. AstraZeneca reported a strong rise in interim profit, as revenue edged up and amid lower cost of sales. International Consolidated Airlines Group said it expects to be back to pre-pandemic capacity by the end of the year.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 17.0 points, 0.2%, at 7,675.76

----------

Hang Seng: up 1.4% at 19,918.53

Nikkei 225: closed down 0.4% at 32,759.23

S&P/ASX 200: closed down 0.7% at 7,403.60

----------

DJIA: closed down 237.40 points, or 0.7%, at 35,282.72

S&P 500: closed down 0.6% to 4,537.41

Nasdaq Composite: closed down 0.6% to 14,050.11

----------

EUR: down at USD1.0981 (USD1.0996)

GBP: down at USD1.2786 (USD1.2865)

USD: soft at JPY139.09 (JPY141.07)

Gold: up at USD1,952.24 per ounce (USD1,944.93)

Oil (Brent): up at USD83.85 a barrel (USD83.59)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

18:00 CEST EU bank stress test results

10:00 CEST EU consumer confidence

11:00 IST Ireland GDP

11:00 IST Ireland retail sales

10:00 EDT US Michigan consumer confidence survey

08:30 EDT US personal consumption expenditures

----------

The French economy saw a surprisingly robust performance in the second quarter of this year, growing by 0.5% from the first quarter, the statistics office announced. The figure was well above the INSEE statistics office's own forecast of 0.1% growth for April to June and the expectations of analysts. It was also ahead of the 0.2% quarter growth seen in the first quarter. The strong performance came despite a fall in household consumption in the period as shoppers struggled with in inflation but was boosted by exports, the manufacturing industry and energy production. The robust growth is set to be highlighted by the government of President Emmanuel Macron at a time of multiple domestic political challenges and Economy Minister Bruno Le Maire described the performance as "remarkable".

----------

BROKER RATING CHANGES

----------

RBC cuts PageGroup price target to 570 (610) pence - 'outperform'

----------

COMPANIES - FTSE 100

----------

Fresh from scandal, Natwest reported its interim results, touting its "robust balance sheet, with a high-quality deposit base, high levels of liquidity and a well-diversified loan book". In the first half of 2023, total income rose to GBP7.73 billion from GBP6.22 billion a year before, as net interest income came in at GBP5.73 billion from GBP4.33 billion. Operating pretax profit climbed to GBP3.59 billion from GBP2.62 billion. It declared an interim dividend of 5.5 pence and intends to begin a buyback of up to GBP500 million in the second half, in addition to the GBP1.3 billion buyback completed in the second quarter. Its CET1 ratio fell by 70 basis points to 13.5% at the end of June, mostly reflecting capital distributions. Customer deposit balances were stable in the second quarter after the outflows seen in the first quarter, it noted. Customer deposits excluding central items fell by GBP11.8 billion to GBP421.1 billion over the first half. It reiterated guidance provided in its annual report, but said 2023 bank net interest margin is now expected to be less than 3.20%, with a current view of around 3.15%. Senior bosses at the bank are set to face scrutiny from shareholders following the dramatic fallout in the row sparked by Nigel Farage over the closure of his Coutts bank account. The scandal culminated in the resignation of NatWest CEO Alison Rose and the boss of Coutts, which is owned by the banking group. The earnings report comes at a time of volatility for the bank with the two bosses resigning and the group's board facing pressure to explain the events leading up to the fallout.

----------

Standard Chartered launched a new USD1 billion share buyback programme, as it reported a 20% rise in profit in the first half of 2023 and raised its guidance for the full year. The London-based, Asia-focused bank said it is "strongly profitable, highly liquid, and well capitalised". Pretax profit in the six months that ended June 30 was USD3.32 billion, up 20% from USD2.77 billion a year before. Operating income increased by 11% to USD9.13 billion from USD8.23 billion, and StanChart also benefitted from a reduced credit impairment of USD161 million, down from USD263 million a year before. StanChart declared a 6 cents per share ordinary interim dividend, up 50% from a year before. Looking ahead to all of 2023, StanChart said it expects income to increase by 12% to 14% at constant currency. It expects net interest margin to average about 170 basis points over the full year, and it expects a return on tangible equity of 10%.

----------

AstraZeneca said pretax profit surged to GBP4.35 billion in the first half 2023, from just USD800 million a year before. Revenue rose edged up to USD22.30 billion from USD22.16 billion. "Each of our non-Covid-19 therapy areas saw double-digit revenue growth, with eight medicines delivering more than USD1 billion of revenue in the first half, demonstrating the strength of our business," said CEO Pascal Soriot. He also noted strong growth in medicines including Ultomiris, Imfinzi/Imjudo and Farxiga, with revenue growth 64%, 57% and 40% respectively. Astra maintained its interim dividend at USD0.93. The company reiterated annual guidance, expecting revenue to increase by a low-to-mid single-digit percentage at constant exchange rates. Excluding Covid-19 medicines, revenue is expected to increase by a low double-digit percentage at CER. It also expects revenue to return to growth in China, and rise by a low-to-mid single-digit. Core earnings per share are expected to increase by a high single-digit to low double-digit percentage.

----------

The parent company of British Airways made a record operating profit between January and June, it has announced. International Consolidated Airlines Group said its operating profit in the first half of 2023 reached EUR1.3 billion, up from a loss of EUR446 million in the same period last year. Revenue reached EUR13.6 billion, an increase of nearly 45% year-on-year. IAG said the capacity of its flights has been restored to 94% of pre-pandemic levels, and it expects to be back to pre-pandemic capacity by the end of the year. It attributed this to a "strong leisure traffic recovery", noting the premium leisure segment "continued to perform very well".

----------

COMPANIES - FTSE 250

----------

Jefferies said that Summit DT Equity Holdings completed the sale of 20.8 million shares in Darktrace to a "limited number of institutional investors". The shares represent a 3.0% stake in the cybersecurity company. Darktrace will not receive any proceeds from the placing.

----------

OTHER COMPANIES

----------

Chip company TSMC said it is determined to "keep its roots in Taiwan", as it launched a massive new research and development facility in the northern city of Hsinchu on Friday. Taiwan Semiconductor Manufacturing Co controls more than half the world's output of microchips, which are the lifeblood of the modern global economy, powering everything from coffee machines and smartphones to cars and missiles. Much of its manufacturing base is in Hsinchu, where its state-of-the-art facilities are producing ever-smaller silicon wafers that have skyrocketed in demand, especially due to the recent boom in AI-related technology. CEO CC Wei said Friday that TSMC intends to keep the heart of its technological prowess in Taiwan. "We want to use this opportunity to show Taiwanese people TSMC's determination to keep its roots in Taiwan," Wei said at the Friday launch of its R&D facility.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.